ABOVE: Dr. John Byrd, left, with his mentor Dr. Tom Goodwin, center, on the day Byrd received his Hendrix Odyssey Medal in 2015. Also pictured is fellow Odyssey Medalist Dr. Omer Shedd, right.
A new therapeutic agent discovered and developed at Ohio State University will soon be used for cancer treatment at the patient's bedside as part of a clinical trial.
Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) led a global study that identified ...
Glioblastoma (GBM) is the most lethal brain tumor, with a median survival rate of merely 12-16 months after diagnosis. Despite surgical, radiation and chemotherapy treatments, the two-year survival ...